IR Calendar

The American Society of Nephrology’s Kidney Week 2020

Oct 22 – Oct 23, 2020

Title: Treatment of SLE with or without nephritis with the Immunoproteasome Inhibitor KZR-616: Initial Results of the MISSION Study
Abstract N°: PO1913 (e-poster presentation)
Presenters: Samir Parikh, MD, Assistant Professor of Medicine, The Ohio State University Wexner Medical Center
Session: Glomerular Diseases: Clinical, Outcomes, and Trials - 3
Date and Time: October 22, 10:00 am – 12:00 pm ET

Title: KZR-616, A Selective Inhibitor of the Immunoproteasome: Preclinical and Clinical Mechanism of Action Studies in Lupus Nephritis
Abstract N°: FR-OR38
Presenter: Tony Muchamuel, MS, Director of Pharmacology and Toxicology, Kezar Life Sciences
Session: Glomerular Diseases: Charting New Territory [OR1202]
Date and Time: October 23, 2020, 5:00 – 7:00pm ET

8th Annual Meeting of the International Cytokine & Interferon Society (Cytokines 2020)

Nov 2, 2020 6:15 pm EDT

Title: Blockade of Cytokine Production and Attenuation of Experimental Arthritis Progression by Novel Small Molecule Inhibitors of Sec61-Dependent Protein Secretion
Session: Lightning Talk Session 2: Autoinflammation and autoimmunity
Presenter: Janet L. Anderl, MS, Senior Scientist, Kezar Life Sciences
Date: November 2, 2020, 6:15 – 8:15 pm ET

American College of Rheumatology’s Convergence 2020

Nov 7 – Nov 9, 2020

Title: Treatment of SLE with or without Nephritis with the Immunoproteasome Inhibitor KZR-616: Updated Results of the MISSION Study
Abstract N°: 0855
Session: SLE – Treatment Poster I
Presenter: Richard Furie, M.D., Chief of the Division of Rheumatology at Northwell Health
Date: November 7, 2020, 9:00 – 11:00 am ET

Title: KZR-616, a First-in-class Selective Inhibitor of the Immunoproteasome, Ameliorates Polymyositis in a Murine Model
Abstract N°: 1916
Session: Systemic Sclerosis & Related Disorders – Basic Science Poster
Presenter: Marta Del Rio Oliva, Ph.D. candidate, Clinical Immunology, University of Konstanz
Date: November 9, 2020 at 9:00 – 11:00 am ET

The Society for Immunotherapy of Cancer’s Annual Meeting

Nov 11 – Nov 13, 2020

Title: Small molecule inhibitors of Sec61 co-translational translocation regulate the phagocytosis checkpoint molecule CD47
Abstract N°: 207
Session: Checkpoint Blockcade Therapy - poster session
Presenter: Jennifer Whang, Ph.D., Senior Scientist, Kezar Life Sciences
Date: November 11, 5:15 – 5:45pm ET; November 13, 4:40-5:10pm ET